AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Radioimmunoassays Market Trajectory & Analytics Report 2020: Market is Expected to Reach $499.9 Million in 2027 with Reagents & Kits Expected to Account for $406.4 Million - ResearchAndMarkets.com

December 21, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 21, 2020--

The “Radioimmunoassays - Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

ADVERTISEMENT

Global Radioimmunoassays Market to Reach $499.9 Million by 2027

Amid the COVID-19 crisis, the global market for Radioimmunoassays estimated at US$397.6 Million in the year 2020, is projected to reach a revised size of US$499.9 Million by 2027, growing at a CAGR of 3.3% over the period 2020-2027.

Reagents & Kits, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$406.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analyzers segment is readjusted to a revised 1.9% CAGR for the next 7-year period.

The U. S. Market is Estimated at $116.9 Million, While China is Forecast to Grow at 3.1% CAGR

The Radioimmunoassays market in the U. S. is estimated at US$116.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$89 Million by the year 2027 trailing a CAGR of 3.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Radioimmunoassay Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Beckman Coulter, Inc.
  • Berthold Technologies GmbH & Co. KG
  • Cisbio Bioassays
  • DiaSorin SpA
  • Diasource Immunossays S. A
  • DRG International, Inc.
  • Euro Diagnostica AB
  • IBL International GmbH
  • Izotop
  • MilliporeSigma
  • MP Biomedicals LLC
  • PerkinElmer, Inc.
  • Stratec Biomedical AG

     

ADVERTISEMENT

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • Radioimmunoassays Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • Radioimmunoassays Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
  • Radioimmunoassays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • Reagents & Kits (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • Reagents & Kits (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
  • Reagents & Kits (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • Analyzers (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • Analyzers (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
  • Analyzers (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • Hospital (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • Hospital (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019
  • Hospital (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • Pharmaceutical Industry (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • Pharmaceutical Industry (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • Pharmaceutical Industry (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • Academics (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
  • Academics (End-Use) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019
  • Academics (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • CROs (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
  • CROs (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019
  • CROs (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • Research (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
  • Research (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • Research (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • Clinical Diagnostics (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
  • Clinical Diagnostics (Application) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019
  • Clinical Diagnostics (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 44

For more information about this report visit https://www.researchandmarkets.com/r/omxikb

View source version on businesswire.com:https://www.businesswire.com/news/home/20201221005537/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/21/2020 10:47 AM/DISC: 12/21/2020 10:47 AM

http://www.businesswire.com/news/home/20201221005537/en